Welcome to LookChem.com Sign In|Join Free

CAS

  • or

444344-91-6

Post Buying Request

444344-91-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

444344-91-6 Usage

General Description

4-(Benzyloxycarbonylamino)bicyclo[2.2.2]octane-1-carboxylic acid is a chemical compound with a complex structure. It is classified as an amino acid derivative with a carboxylic acid group. The compound contains a bicyclic octane ring and a benzyloxycarbonyl group, which are both important structural features. 4-(BenzyloxycarbonylaMino)bicyclo[2.2.2]octane-1-carboxyli- -cacid may have potential uses in pharmaceuticals or organic synthesis due to its unique structure and functional groups. Further research may be needed to fully understand its properties and potential applications.

Check Digit Verification of cas no

The CAS Registry Mumber 444344-91-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,4,3,4 and 4 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 444344-91:
(8*4)+(7*4)+(6*4)+(5*3)+(4*4)+(3*4)+(2*9)+(1*1)=146
146 % 10 = 6
So 444344-91-6 is a valid CAS Registry Number.

444344-91-6Relevant articles and documents

CYANO-PYRIMIDINE INHIBITORS OF EGFR/HER2

-

, (2021/07/17)

Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders associated with EGFR and/or HER2 activity.

BICYCLIC AMIDE DERIVATIVES

-

Page/Page column 12, (2008/06/13)

Novel bicycloamide derivatives (general formula (1)) and pharmaceutically acceptable salts thereof effectively inhibit DPP-IV. The bicycloamide derivatives are represented by the general formula (1): Pharmaceutically acceptable salts thereof are also included (Example: (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile)).

BICYCLOESTER DERIVATIVE

-

Page/Page column 12, (2010/11/24)

SUMMARY Novel bicycloester derivatives and pharmaceutically acceptable salts thereof have high DPP-IV inhibitory activity. SOLVING MEANS The novel bicycloester derivatives are represented by the general formula (1): Pharmaceutically acceptable salts there

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 444344-91-6